• OPEN AN ACCOUNT
Indian Indices
Nifty
24,971.90 -140.50
(-0.56%)
Sensex
81,896.79 -511.38
( -0.62%)
Bank Nifty
56,059.35 -193.50
( -0.34%)
Nifty IT
38,414.10 -577.35
( -1.48%)
Global Indices
Nasdaq
42,233.20 40.53
(0.10%)
Dow Jones
5,989.55 -12.32
(-0.21%)
Hang Seng
38,330.35 -72.88
(-0.19%)
Nikkei 225
8,774.65 -17.15
(-0.20%)
Forex
USD-INR
86.67 0.24
(0.27%)
EUR-INR
99.45 0.06
(0.06%)
GBP-INR
116.39 0.20
(0.17%)
JPY-INR
0.60 0.00
(-0.02%)

EQUITY - MARKET SCREENER

Beta Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
535022
INE351Y01019
127.8259206
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BETA
95.48
1790.77
EPS(TTM)
Face Value()
Div & Yield %
18.58
10
0
 

INDRA and AXISCADES Technologies sign agreement
Jun 17,2025
Indra, a European-based global leader in defense, aerospace, and strategic systems, and AXISCADES a prominent technology solutions provider in defense, aerospace and strategic electronics, are proud to announce a strategic alliance. Indra is keen to acquire defense-related products and services from AXISCADES, which will be delivered through AXISCADES’ comprehensive design, development, production, and supply chain center. Both companies are actively exploring joint product development for the Indian and global markets, potentially adapting existing Indra products or creating new ones specifically tailored to meet customer needs.